In silico analysis and molecular identification of an anaphase-promoting complex homologue from human pathogen Entamoeba histolytica
Background
Amoebiasis, being endemic worldwide, is the second leading cause of parasite-associated morbidity and mortality after malaria. The human parasiteEntamoeba histolyticais responsible for the disease.Metronidazoleis considered as the gold standard for the treatment of amoebiasis, but thisantibioticis carcinogenic and the development ofantibiotic resistanceagainstE. histolyticais a major health concern.Chromosome segregationis irregular in this parasite due to theabsenceof a fewcell cycle checkpointproteins. Anaphase-promoting complex (APC/C or cyclosome) is anE3 ubiquitin ligasethat synchronizes chromosome segregation andanaphaseprogression via the ubiquitin-proteasome system. Proteasome is considered to be an attractive drug target forprotozoanparasites. For the present study, EhApc11 fromE. histolytica, a homologue of Apc11 in humans, is selected for elucidating its structural and functional aspects by detailed in silico analysis and molecular methods. Its physicochemical characteristics, identification of probable interactors, 3D model and quality analysis are done using standard bioinformatics tools. cDNA sequence of EhAPC11 has been further cloned for molecular characterization.
Result
Conserved domain analysis revealed that EhApc11 belongs to the RING (really interesting new gene) superfamily and hasligand bindingcapacity. Expression study inEscherichia coliBL21 (DE3) revealed that the molecular weight ofglutathioneS-transferase (GST)-tagged protein is ~ 36 kDa.
Conclusion
EhApc11 is a hydrophilic, thermostable, extracellular protein with potentantigenicity. The study will serve as a groundwork for future in-depth analysis regarding the validation of protein-protein interaction of EhApc11 with its substrates identified by STRING analysis and the potential of EhApc11 to serve as an anti-amoebic drug target.